Skip to Main Content

Paper Details

Rethinking the value of survival: clinical trials should measure patient preferences for survival on entry to trials.
J Clin Epidemiol
3
2016
Author NameAffiliation
Jason N DoctorDepartment of Pharmaceutical Health and Economics, Schaeffer Center for Health Policy and Economics, University of Southern California
Daniella MeekerUniversity of Southern California
  • 1 - 2

Datasets

Release 1.2